EUVIMEDEUVIMED entdecken
Crossref

Paracorporeal continuous-flow ventricular assist devices (cfVADs) for children less than 20 kg: Challenging the paradigm in the smallest patients

Ryan R Davies, Mehreen Iqbal, Jodie Lantz-Thomason, Sydney Carrington, Robert D B Jaquiss, Sirine A Baltagi, Javier J Lasa, Ryan J Butts

The Journal of Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1016/j.jtcvs.2025.04.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Ryan R Davies und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, Dallas, Tex; Heart Center at Children's Health, Dallas, Tex. Elect…. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Small children with heart failure are at high risk for waitlist mortality, experience high complication rates on ventricular assist devices (VADs), and remain the only population not routinely supported with continuous-flow ventricular assist devices (cfVADs). We sought to describe the clinical course and outcomes of an exclusively cfVAD strategy in the management of small children with heart failure. METHODS: This was a retrospective review of all patients less than 20 kg supported on paracorporeal VADs at a single institution (2017-2024), stratified by univentricular versus biventricular physiology pre-VAD. Outcomes after VAD implantation, including Advanced Cardiac Therapies Improving Outcomes Network-defined serious adverse events, competing risks, and successful support (survival to transplant or 180 days of support, or alive on support at study end), were assessed. RESULTS: Sixty-three patients were supported on paracorporeal cfVADs. Presupport extracorporeal membrane oxygenation was common (22, 34.9%). Median days of support was 74 days (interquartile range, 32-133 days, maximum 811 days). Successful support was achieved in 52 (82.5%) patients (univentricular: 21 [70%]; biventricular: 31 [93.9%]; P = .01). Strokes occurred in 10 patients (15.9%) at a rate of 0.7 per patient-year of support. Outcomes were similar in patients less than 5 kg (n = 25, stroke: 16%, primary end-point success: 84.0%). CONCLUSIONS: An entirely cfVAD strategy, including predominantly paracorporeal cfVADs, in small patients less than 20 kg achieves excellent results, including high rates of successful support and low rates of hemorrhagic and neurologic complications. These results should challenge the current paradigm of using pulsatile VADs, especially in small patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart FailureHumansRetrospective StudiesFemaleMaleInfantTreatment OutcomeProsthesis DesignChild, PreschoolTime FactorsRisk FactorsChildExtracorporeal Membrane OxygenationInfant, NewbornAge FactorsVentricular Function, Left

Stichwörter der Autor:innen

congenitalmechanical circulatory supportpediatricventricular assist device

Autor:innen und Institutionen

  • Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, Dallas, Tex; Heart Center at Children's Health, Dallas, Tex. Electronic address: ryan.davies@utsouthwestern.edu.
  • Heart Center at Children's Health, Dallas, Tex; Department of Pediatrics (Cardiology), UT Southwestern Medical Center, Dallas, Tex.
  • Heart Center at Children's Health, Dallas, Tex; UT Southwestern Medical Center, Dallas, Tex.
  • Heart Center at Children's Health, Dallas, Tex.
  • Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, Dallas, Tex; Heart Center at Children's Health, Dallas, Tex.

Zitieren

APA

Davies, R. R., Iqbal, M., Lantz-Thomason, J., Carrington, S., Jaquiss, R. D. B., Baltagi, S. A., Lasa, J. J., & Butts, R. J. (2025). Paracorporeal continuous-flow ventricular assist devices (cfVADs) for children less than 20 kg: Challenging the paradigm in the smallest patients. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.04.024

Vancouver

Davies RR, Iqbal M, Lantz-Thomason J, Carrington S, Jaquiss RDB, Baltagi SA, et al. Paracorporeal continuous-flow ventricular assist devices (cfVADs) for children less than 20 kg: Challenging the paradigm in the smallest patients. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2025.04.024

BibTeX
@article{Davies2025,
  author = {Davies, Ryan R and Iqbal, Mehreen and Lantz-Thomason, Jodie and Carrington, Sydney and Jaquiss, Robert D B and Baltagi, Sirine A and Lasa, Javier J and Butts, Ryan J},
  title = {Paracorporeal continuous-flow ventricular assist devices (cfVADs) for children less than 20 kg: Challenging the paradigm in the smallest patients},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1016/j.jtcvs.2025.04.024}
}
Kostenlos starten →